Local Institution - 0102
Athens 115 28
1 studies enrolling now · 2 studies all time
What they study most
Relapsed/Refractory Non-Hodgkin Lymphoma, Urothelial Cancer
Studies at this site
- A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas — Recruiting now
- Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer — Running, not enrolling